The European Artificial Organ Scene: Present Status

Vanholder, Raymond; Cañizo, Juan F. Del; Sauer, Igor M.; Stegmayr, Bernd

doi:10.1111/j.1525-1594.2005.29079.x

Cited by 9 publications

(4 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… EUTox congresses and purpose Mission statement A slide show on “renal failure” A slide show reviewing EUTox activities The list of members A page on the publications of the group, displaying the >2500 publications since 1995 by members of the group, the 69 common publications to which at least two research institutes belonging to EUTox contributed in collaboration, and the abstract, references, and links to the eight position statements and review papers by EUTox (2–9). The meetings of the group Sponsors and linked societies A link to the uremic toxin database (http://www.nephro-leipzig.de/eutoxdb/index.php) …”

Section: Websitementioning

confidence: 99%

“…A page on the publications of the group, displaying the >2500 publications since 1995 by members of the group, the 69 common publications to which at least two research institutes belonging to EUTox contributed in collaboration, and the abstract, references, and links to the eight position statements and review papers by EUTox (2–9).…”

Section: Websitementioning

confidence: 99%

“… Eight specific EUTox reviews or position statements have by now been published, devoted to respectively: uremic toxins with potential cardiovascular toxicity (3), uremic solute concentrations in severe kidney disease and their reported variability (4,6,8), an update on European artificial organ research (5), the link between chronic kidney disease, uremic toxicity, and cardiovascular damage (2), technical approaches for uremic toxicity research (7), and bench to bedside uremic toxin research (9). …”

Section: Publicationsmentioning

confidence: 99%

See 2 more Smart Citations

PROGRESS IN UREMIC TOXIN RESEARCH: The Role of EUTox in Uremic Toxin Research

Vanholder

Abou-Deif

Argilés

et al. 2009

Seminars in Dialysis

Self Cite

View full text Add to dashboard Cite

In this publication, we review the activities of the European Uremic Toxin Work Group (EUTox) in the field of uremic toxin research. Founded in 1999 under the umbrella of the European Society of Artificial Organs (ESAO), and active since 2000, this group focuses essentially on questions related to solute retention and removal during chronic kidney disease, and on the deleterious impact of those solutes on biological/biochemical systems. As of January 1, 2009, the group had met 28 times; it organized the third meeting, "Uremic Toxins in Cardiovascular Disease," which took place in October 2008 in Amiens, France. The current group is composed of 25 members belonging to 23 European research institutions. As of November 1, 2008, in total 69 papers had been published to which at least two different research groups belonging to EUTox have contributed in a collaborative effort. Of these, 40 papers were on original research and eight were specific EUTox reviews or position statements. A website (http://www.eutox.info) summarizes all relevant information concerning the work group. EUTox also developed an interactive uremic toxin database, where concentrations of known toxins are displayed, to be used by researchers in the field. In the future, EUTox intends to continue its focus on bench to bedside research with specific consideration of proteomics, metabonomics, secretomics, and genomics.

show abstract

Section: Websitementioning

confidence: 99%

Section: Websitementioning

confidence: 99%

Section: Publicationsmentioning

confidence: 99%

See 1 more Smart Citation

PROGRESS IN UREMIC TOXIN RESEARCH: The Role of EUTox in Uremic Toxin Research

Vanholder

Abou-Deif

Argilés

et al. 2009

Seminars in Dialysis

Self Cite

View full text Add to dashboard Cite

show abstract

“…In the September issue, the abstracts from this meeting were published. In the June issue, Dr. Vanholder et al (1) summarized the current status of artificial organs developments in Europe. In the August issue, Drs.…”

mentioning

confidence: 99%

Artificial Organs 2005: A Year in Review

Malchesky¹

2006

Artificial Organs

View full text Add to dashboard Cite

Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis

Szczepiórkowski

Winters

Bandarenko

et al. 2007

J of Clinical Apheresis

450

519

View full text Add to dashboard Cite

The American Society for Apheresis (ASFA) Apheresis Applications Committee is charged with a review and categorization of indications for therapeutic apheresis. This elaborate process had been undertaken every 7 years resulting in three prior publications in 1986, 1993, and 2000 of "The ASFA Special Issues." This article is the integral part of the Fourth ASFA Special Issue. The Fourth ASFA Special Issue is significantly modified in comparison to the previous editions. A new concept of a fact sheet has been introduced. The fact sheet succinctly summarizes the evidence for the use of therapeutic apheresis. A detailed description of the fact sheet is provided. The article consists of 53 fact sheets devoted to each disease entity currently categorized by the ASFA. Categories I, II, and III are defined as previously in the Third Special Issue. However, a few new therapeutic apheresis modalities, not yet approved in the United States or are currently in clinical trials, have been assigned category P (pending) by the ASFA Clinical Categories Subcommittee. The diseases assigned to category IV are discussed in a separate article in this issue.

show abstract

The European Artificial Organ Scene: Present Status

Cited by 9 publications

References 39 publications

PROGRESS IN UREMIC TOXIN RESEARCH: The Role of EUTox in Uremic Toxin Research

PROGRESS IN UREMIC TOXIN RESEARCH: The Role of EUTox in Uremic Toxin Research

Artificial Organs 2005: A Year in Review

Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis

Contact Info

Product

Resources

About